P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris
Public ClinicalTrials.gov record NCT02242760. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Randomized, Evaluator-Blinded, Vehicle-Controlled Study Comparing the Efficacy, Tolerability, and Safety of SB204 Gel and Vehicle Gel Once or Twice Daily in the Treatment of Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, multi-center, double-blinded study in subjects with moderate to severe acne vulgaris. Subjects eligible to enroll will be treated once or twice daily with 2 concentrations of a topical drug in development or a vehicle. Subjects will be treated for up to 12 weeks.
Study identification
- NCT ID
- NCT02242760
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 213 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2014 (Type not available)
- Primary completion
- Jun 2015 (Actual)
- Completion
- Aug 2015 (Actual)
- Last update posted
- May 31, 2023
2014 – 2015
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Qst acne site #1 | Hot Springs | Arkansas | 71913 | — |
| QST Site #118 | Encinitas | California | 92024 | — |
| QST Site #111 | San Diego | California | 92123 | — |
| QST Site #113 | San Diego | California | 92123 | — |
| QST Site #119 | Santa Monica | California | 90404 | — |
| QST Site #103 | Boca Raton | Florida | 33486 | — |
| QST Site # 110 | Pinellas Park | Florida | 33781 | — |
| QST Site # 116 | Newnan | Georgia | 302636 | — |
| QST Site #117 | Louisville | Kentucky | 40202 | — |
| QST Site #112 | Detroit | Michigan | 48202 | — |
| QST Site #120 | Warren | Michigan | 48088 | — |
| QST Site # 121 | Minneapolis | Minnesota | 55432 | — |
| QST Site #107 | New York | New York | 10155 | — |
| QST Site #108 | Rochester | New York | 14623 | — |
| QST Site #109 | Rochester | New York | 14625 | — |
| QST Site #104 | Stony Brook | New York | 11790 | — |
| QST Site # 102 | San Antonio | Texas | 78229 | — |
| QST Site #106 | Salt Lake City | Utah | 84117 | — |
| QST #105 | Lynchburg | Virginia | 24501 | — |
| QST Site #114 | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02242760, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2023 · Synced Nov 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02242760 live on ClinicalTrials.gov.